Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.
Marni B SiegelYasunori KogureNaser Ansari-PourYuki SaitoHann-Hsiang ChaoJonathan H ShepherdMariko TabataOlufunmilayo I OlopadeDavid C WedgeKatherine A HoadleyCharles M PerouKeisuke KataokaPublished in: Cancer research communications (2023)
mutation and a resultant selected pattern of aneuploidies cause an aggressive transcriptional program including upregulation of glycolysis signature with prognostic implications. Importantly, basal-like breast cancer demonstrates genetic and/or phenotypic changes closely related to squamous tumors including 5q deletion that reveal alterations that could offer therapeutic options across tumor types regardless of tissue of origin.